(lp0
S"Here's Why the Best Is Yet to Come for Illumina, Inc. Motley Fool - Mar 21, 2017 A cursory glance at the stock chart for Illumina, Inc.  might make you think the good times are over for the genomic-sequencing leader."
p1
aS"Insider Trading Activity Illumina, Inc.   EVP Sold 1672 shares ... Market Exclusive - 1 hour ago Omead Ostadan , EVP of Illumina, Inc.  reportedly Sold 1,672 shares of the company's stock at an average price of 170 for a total transaction amount of $284,240.00 SEC Form."
p2
aS"1 Huge Reason to Buy Illumina, Inc. Stock Now Motley Fool - Mar 8, 2017 The genomic-sequencing company's stock skyrocketed from 2012 through mid-2015. And then it didn't. Beginning in July 2015 and extending throughout most of last year, Illumina fumbled, flopped, and floundered. Now, however, Illumina looks to again be a&nbsp;...Illumina, Inc.  Quarterly EPS At $1.22 - Stock Observer"
p3
aS'Kailos Genetics Announces Co-marketing Agreement with Illumina, Inc. for ... Business Wire  - Mar 21, 2017 BUSINESS WIRE)--Kailos Genetics, a personalized medicine company offering a leading-edge suite of tools for next-generation sequencing -based assays, today announced it has entered into a co-marketing agreement with Illumina, Inc. (NASDAQ:&nbsp;...'
p4
aS"Earnings Clues on Regeneron Pharmaceuticals, Inc. , Illumina, Inc. (ILMN ... StockNewsJournal - Mar 27, 2017 Illumina, Inc. , maintained return on investment for the last twelve months at 13.16, higher than what Reuters data shows regarding industry's average.Latest Stocks: Illumina, Inc.  Expected to Earn FY2016 Earnings of $3.30 ... - Petro Global News 24Illumina, Inc.  Downgraded by Vetr Inc. to Buy - Chaffey Breeze"
p5
aS'Big Banks Continue to be Large Stakeholders in Illumina, Inc.  Midway Monitor - 9 hours ago Based on the lastest quarterly filings, institutions continue to be large stakeholders in Illumina, Inc. .'
p6
aS'Analyst Views On Top Movers In Recent Trade: Illumina, Inc. , AGNC ... Post Analyst - 16 hours ago Illumina, Inc. has a consensus hold rating from 20 Wall Street analysts, and the number of shares currently sold short amount to at least 3.44% of shares outstanding.'
p7
aS'Illumina, Inc.  Stock Is Nearing Breakout Territory Investorplace.com - Mar 13, 2017 Biotechnology stocks have fared well year-to-date, and they even managed to recover well after a short-lived intra-week scare, closing the week near their highs.'
p8
aS'Illumina Inc.  Rises 2.62% for March 22 Equities.com - Mar 22, 2017 Among the biggest risers on the S&amp;P 500 on Wednesday March 22 was Illumina Inc. , popping some 2.62% to a price of $167.79 a share with some 1.12 million shares trading hands.'
p9
aS'Illumina, Inc.  Analyst Estimates &amp; Target Update Aiken Advocate - 20 hours ago Sell-side equity research analysts have handed shares of Illumina, Inc.  a short term price target of $156.'
p10
a.